Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLE
Clinical trial NCT05492799 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05492799
- Sponsor
- Allievex Corporation
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2027-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.